In a bid to strengthen its in vitro diagnostics offering, surface modification and drug delivery firm SurModics has purchased the CodeLink activated slide microarray business from GE Healthcare.
Eden Prairie, Minnesota-based SurModics originally began manufacturing surface chemistry technology for the microarray sector in 1999 and marketed the technology...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?